Clinical Research Directory
Browse clinical research sites, groups, and studies.
Magseed Pro(R)/ Sentimag(R) Gen3
Sponsor: Endomagnetics Ltd.
Summary
The purpose of this study is to provide prospective evidence that the Magseed Pro® marker /Sentimag® Gen3 system is safe and effective for marking A. suspicious/biopsy-proven positive axillary lymph nodes; and B. soft tissue lesions including cancer and pre-cancerous change in the breast
Official title: A Prospective, Multi Center, International, Open Label Study of the Use of Magseed Pro(R) Markers and Sentimag(R) Gen3 to Localize Breast Lesions and Suspicious/biopsy-proven Positive Lymph Nodes in Breast Cancer Patients
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
224
Start Date
2023-03-02
Completion Date
2026-06-30
Last Updated
2024-09-19
Healthy Volunteers
No
Conditions
Interventions
Magseed Pro(R) and Sentimag(R) Gen3 by Endomagnetics
placement of Magseed Pro \& localisation with Sentimag Gen3 in axillary lymph nodes and/or breast lesions
Locations (6)
Marienhospital Bottrop GmbH
Bottrop, Germany
AGAPLESION Markus Frankfurter Diakonie Kliniken gGmbH
Frankfurt, Germany
Technical University Munich
Munich, Germany
Guy's Hospital
London, United Kingdom
Royal Marsden Hospital
London, United Kingdom
University Hospital South Manchester
Manchester, United Kingdom